AZTR
AMEX
$0.14
Azitra Inc (AZTR)
Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. The company is headquartered in Branford, Connecticut.
Sector:
Healthcare
Industry:
Biotechnology
Target: $0.78 (+453.57%)
Market Cap
$2.22M
P/B Ratio
0.20
Beta (5Y)
0.90
Price Chart
Valuation
Market Cap$2.22M
P/S239.97
P/B0.20
Profitability
EBITDA-$12M
EPS-$1.10
Growth & Risk
Beta (5Y)0.90
Sharpe Ratio-1.36